Wave of Acquisitions Hits ADC Cancer Treatment Space
The end of 2020 saw several big pharma acquisitions of companies developing antibody-drug conjugate drugs…
05/01/2021 - 7 minutes
ADC Therapeutics
A Year to Remember: The Biggest European Biotech News in 2020
The Covid-19 pandemic caused huge disruption for European biotech in 2020, but the industry pulled…
28/12/2020 - 12 minutes
Update: ADC Therapeutics’ IPO Hits Above Target with €215M
Update (15/05/2020): The Swiss biotech ADC Therapeutics has priced its IPO on the New York…
15/05/2020 - 4 minutes
It’s News Roundup Time! Big Data, RNA Therapies, and More …
Try as we might, we can’t cover every bit of news out there. So relax…
18/10/2019 - 3 minutes
ADC Therapeutics Cancels Nasdaq IPO Amidst Market Growth Fears
The Swiss biotech ADC Therapeutics has withdrawn its application for a €182M ($200M) Nasdaq IPO,…
04/10/2019 - 2 minutes
ADC Therapeutics and SOPHiA Genetics Team Up to Personalize Cancer Treatment
Two companies based in Lausanne, Switzerland -- ADC Therapeutics and the genomics company SOPHiA Genetics…
06/08/2019 - 2 minutes
Update: Swiss Biotech’s Series E Expanded to €271M to Commercialize Antibody-Guided Cancer Chemotherapy
Update (09/07/2019): The Switzerland-based ADC Therapeutics has completed the final closing of a €271M ($303M)…
09/07/2019 - 3 minutes
Top 10 Biotechs in Lausanne
The Swiss city of Lausanne is perhaps best known as a hub of international sport,…
08/05/2019 - 7 minutes
Money, Money, Money! Europe’s Best-Funded Biotechs in 2018
Besides struggling with ambitious New Year’s resolutions and post-holiday diets, January is a time where…
20/02/2018 - 11 minutes
New Antibody-Drug Conjugate Offers Hope to Hard-to-Treat Cancer Patients
ADC Therapeutics has tested its antibody-drug conjugate technology in drug-resistant cancers, yielding encouraging results. Swiss biotech…
11/12/2017 - 3 minutes
Europe’s Brightest Stars: The 9 Best Biotech Companies of 2017
Tis the season for Glühwein, Tannenbäume, and lights in Berlin, and Labiotech is celebrating with…
05/12/2017 - 6 minutes
Swiss ADCs Show Impressive Responses for Lymphoma in Phase I
ADC Therapeutics has presented preliminary Phase I data in lymphoma patients suggesting its ADC technology…
16/06/2017 - 2 minutes
